Document Actions

Publications

2024

  • Schaefer SM*; Kaiser A*; Eichner G; Fasshauer M(2024): Association of sugar intake from different sources with cardiovascular disease incidence in the prospective cohort of UK Biobank participants. In: Nutrition Journal 23 (1) 22. DOI: 10.1186/s12937-024-00926-4

2023

  • Kaiser A*; Schaefer SM*; Behrendt I; Eichner G; Fasshauer M (2023): Association of all-cause mortality with sugar intake from different sources in the prospective cohort of UK Biobank participants. In: The British Journal of Nutrition 130 (2), S. 294–303. DOI: 10.1017/S0007114522003233.
  • Kaiser A*; Schaefer SM*; Behrendt I; Eichner G; Fasshauer M (2023): Association of sugar intake from different sources with incident depression in the prospective cohort of UK Biobank participants. In: European Journal of Nutrition 62 (2), S. 727–738. DOI: 10.1007/s00394-022-03022-7.
  • Metz K-M; Neumann NJ; Fasshauer M (2023): Ultra-processing markers are more prevalent in plant-based meat products as compared to their meat-based counterparts in a German food market analysis. In: Public Health Nutrition 26 (12), S. 2728–2737. DOI: 10.1017/S1368980023002458.
  • Mostafa H; Behrendt I; Meroño T; González-Domínguez R; Fasshauer M; Rudloff S; Andres-Lacueva C; Kuntz S (2023): Plasma anthocyanins and their metabolites reduce in vitro migration of pancreatic cancer cells, PANC-1, in a FAK- and NF-kB dependent manner: Results from the ATTACH-study a randomized, controlled, crossover trial in healthy subjects. In: Biomedicine & pharmacotherapy 158, S. 114076. DOI: 10.1016/j.biopha.2022.114076.
  • Neumann NJ; Eichner G; Fasshauer M (2023): Flavour, emulsifiers and colour are the most frequent markers to detect food ultra-processing in a UK food market analysis. In: Public Health Nutrition 26 (12), S. 3303–3310. DOI: 10.1017/S1368980023002185.
  • Schaefer SM*; Kaiser A*; Behrendt I; Eichner G; Fasshauer M (2023): Association of alcohol types, coffee and tea intake with mortality: prospective cohort study of UK Biobank participants. In: The British Journal of Nutrition 129 (1), S. 115–125. DOI: 10.1017/S000711452200040X.
  • Schaefer SM*; Kaiser A*; Eichner G; Fasshauer M (2023): Association of sugar intake from different sources with incident dementia in the prospective cohort of UK Biobank participants. In: Nutrition Journal 22 (1), S. 42. DOI: 10.1186/s12937-023-00871-8.
  • Schlögl H; Janssen L; Fasshauer M; Miehle K; Villringer A; Stumvoll M; Mueller K (2023): Reward Processing During Monetary Incentive Delay Task After Leptin Substitution in Lipodystrophy-an fMRI Case Series. In: Journal of the Endocrine Society 7 (6), bvad052. DOI: 10.1210/jendso/bvad052.
  • Schlögl H; Villringer A; Miehle K; Fasshauer M; Stumvoll M; Mueller K (2023): Metreleptin Robustly Increases Resting-state Brain Connectivity in Treatment-naïve Female Patients With Lipodystrophy. In: Journal of the Endocrine Society 7 (8), bvad072. DOI: 10.1210/jendso/bvad072.

2022

  • Ambika Manirajan B; Hinrichs A-K; Ratering S; Rusch V; Schwiertz A; Geissler-Plaum R; Eichner G; Cardinale M; Kuntz S; Schnell S (2022): Bacterial Species Associated with Highly Allergenic Plant Pollen Yield a High Level of Endotoxins and Induce Chemokine and Cytokine Release from Human A549 Cells. In: Inflammation 45 (6), S. 2186–2201. DOI: 10.1007/s10753-022-01684-3.
  • Behrendt I; Röder I; Will F; Mostafa H; Gonzalez-Dominguez R; Meroño T; Andres-Lacueva C; Fasshauer M; Rudloff S; Kuntz S (2022): Influence of Plasma-Isolated Anthocyanins and Their Metabolites on Cancer Cell Migration (HT-29 and Caco-2) In Vitro: Results of the ATTACH Study. In: Antioxidants 11 (7). DOI: 10.3390/antiox11071341.
  • Neumann NJ; Fasshauer M (2022): Added flavors: potential contributors to body weight gain and obesity? In: BMC Medicine 20 (1), S. 417. DOI: 10.1186/s12916-022-02619-3.
  • Schaefer SM*; Kaiser A*; Behrendt I; Eichner G; Fasshauer M (2022): Association of Alcohol Types, Coffee, and Tea Intake with Risk of Dementia: Prospective Cohort Study of UK Biobank Participants. In: Brain Sciences 12 (3). DOI: 10.3390/brainsci12030360.
  • Stürzebecher PE; Kralisch S; Schubert MR; Filipova V; Hoffmann A; Oliveira F; Sheikh BN; Blüher M; Kogel A; Scholz M; Kokot KE; Erbe S; Kneuer JM; Ebert T; Fasshauer M; Miehle K; Laufs U; Tönjes A; Boeckel J-N (2022): Leptin treatment has vasculo-protective effects in lipodystrophic mice. In: Proceedings of the National Academy of Sciences of the United States of America 119 (40), e2110374119. DOI: 10.1073/pnas.2110374119.

2021

  • Behrendt I; Fasshauer M; Eichner G (2021): Gluten Intake and All-Cause and Cause-Specific Mortality: Prospective Findings from the UK Biobank. In: The Journal of Nutrition 151 (3), S. 591–597. DOI: 10.1093/jn/nxaa387.
  • Behrendt I; Fasshauer M; Eichner G (2021): Gluten intake and metabolic health: conflicting findings from the UK Biobank. In: European Journal of Nutrition 60 (3), S. 1547–1559. DOI: 10.1007/s00394-020-02351-9.
  • Hoffmann A; Ebert T; Hankir MK; Flehmig G; Klöting N; Jessnitzer B; Lössner U; Stumvoll M; Blüher M; Fasshauer M; Tönjes A; Miehle K; Kralisch S (2021): Leptin Improves Parameters of Brown Adipose Tissue Thermogenesis in Lipodystrophic Mice. In: Nutrients 13 (8). DOI: 10.3390/nu13082499.
  • Mulhem A; Moulla Y; Klöting N; Ebert T; Tönjes A; Fasshauer M; Dietrich A; Schön MR; Stumvoll M; Richter V; Blüher M (2021): Circulating cell adhesion molecules in metabolically healthy obesity. In: International Journal of Obesity (2005) 45 (2), S. 331–336. DOI: 10.1038/s41366-020-00667-4.
  • Rudloff S; Kuntz S; Borsch C; Vazquez E; Buck R; Reutzel M; Eckert GP; Kunz C (2021): Fucose as a Cleavage Product of 2’Fucosyllactose Does Not Cross the Blood‐Brain Barrier in Mice. In: Molecular Nutrition & Food Research. DOI: 10.1002/mnfr.202100045.

2020

  • Behrendt I; Eichner G; Fasshauer M (2020): Association of Antioxidants Use with All-Cause and Cause-Specific Mortality: A Prospective Study of the UK Biobank. In: Antioxidants 9 (12). DOI: 10.3390/antiox9121287.
  • Choi KM; Hwang SY; Han K; Chung HS; Kim NH; Yoo HJ; Seo J-A; Kim SG; Kim NH; Baik SH; Ebert T; Fasshauer M; Blüher M (2020): Interleukin-15 and irisin serum concentrations are not related to cardiometabolic risk factors in patients with type 2 diabetes from Korea and Germany. In: Acta Diabetologica 57 (3), S. 381–384. DOI: 10.1007/s00592-019-01417-3.
  • Ebert T; Gebhardt C; Scholz M; Schleinitz D; Blüher M; Stumvoll M; Kovacs P; Fasshauer M; Tönjes A (2020): Adipocytokines are not associated with gestational diabetes mellitus but with pregnancy status. In: Cytokine 131, S. 155088. DOI: 10.1016/j.cyto.2020.155088.
  • Frenzel SV, Bach S, Ahrens S, Hellbardt M, Hilbert A, Stumvoll M, Fasshauer M, Schlögl H (2020): Closing the gap in conservative obesity therapy: a fully health insurance-financed obesity program - Prospective analysis of clinical real world data. In: Deutsche Medizinische Wochenschrift 145 (14), e78-e86. DOI: 10.1055/a-1134-189.
  • Galuska CE; Rudloff S; Kuntz S; Borsch C; Reutzel M; Eckert G; Galuska SP; Kunz C (2020): Metabolic fate and organ distribution of 13C-3′-sialyllactose and 13C-N-acetylneuraminic acid in wild-type mice – No evidence for direct incorporation into the brain. In: Journal of Functional Foods 75, S. 104268. DOI: 10.1016/j.jff.2020.104268.
  • Kralisch S; Hoffmann A; Estrada-Kunz J; Stumvoll M; Fasshauer M; Tönjes A; Miehle K (2020): Increased Growth Differentiation Factor 15 in Patients with Hypoleptinemia-Associated Lipodystrophy. In: International Journal of Molecular Sciences 21 (19). DOI: 10.3390/ijms21197214.
  • Tönjes A; Hoffmann A; Kralisch S; Qureshi AR; Klöting N; Scholz M; Schleinitz D; Bachmann A; Kratzsch J; Nowicki M; Paeschke S; Wirkner K; Enzenbach C; Baber R; Beige J; Anders M; Bast I; Blüher M; Kovacs P; Löffler M; Zhang M-Z; Harris RC; Stenvinkel P; Stumvoll M; Fasshauer M; Ebert T (2020): Pro-neurotensin depends on renal function and is related to all-cause mortality in chronic kidney disease. In: European Journal of Endocrinology 183 (3), S. 233–244. DOI: 10.1530/EJE-20-0087.

2019

  • Tavernaro I; Rodrigo AM; Kandziora M; Kuntz S; Dernedde J; Trautwein C; Tacke F; Blas‐Garcia A; Bartneck M (2019): Modulating Myeloid Immune Cell Migration Using Multivalently Presented Monosaccharide Ligands for Advanced Immunotherapy. In: Advanced Therapeutics 2 (12). DOI: 10.1002/adtp.201900145.

*equally contributing